Abstract View

Author(s): Nikita Kolte*11, Yogita Shinde2.2

Email(s): 1nikitakolte14@gmail.com

Address:

    1Lecturer,JSPM’s Jayawantrao Sawant Institute of Pharmacy,Hadapsar,Pune, Maharashtra, India. 2 Assistant Professor, Vishwakarma University, School of Pharmacy, Pune, Maharashtra, India..

Published In:   Volume - 2,      Issue - 5,     Year - 2023

DOI: Not Available

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Drugs get delivered to desired tissues, organs, and cells through a variety of drug carriers. Conventional dosage forms of medicament causes difficulties like low solubility, low bioavailability, and drug degradation, side effects, which affects patient compliance. To achieve therapeutic efficacy of the drug suggests that there is a growing need for development of various approaches to deliver the drug. During the past decade, In pharmaceutical research, an entirely novel phase of technological innovation has emerged, with the objective of discovering innovative drug delivery systems. It comprises the method for delivering medications to patients in such a way which increases the concentration of medications inside various body parts. The novel drug delivery system covers various diseases like diabetes, cardiovascular, renal disease, asthma, cancer. These systems include new strategies like liposomes, niosomes, transdermal patches, microsponges, microneedles, microcapsules, nanoparticle, and microchips. Other medication forms of delivery emphasize on getting through specific physical barriers, such the blood-brain barrier, to increase the effectiveness of the medication. Nowadays, with an increase in industrialization, herbal medicines are also administered through novel drug delivery strategies. With demand for innovative and highly efficient pharmaceuticals products, the market holds space for the newest novel drug delivery systems. The current chapter covers the introduction of novel drug delivery, its advantages, challenges, technologies and its future.

Cite this article:
Nikita Kolte, Yogita Shinde. Novel Drug Delivery for Cancer. IJRPAS, Sep-Oct 2023; 2(5): 87-101.


1. Kakde D, Jain D etal. Cancer Therapeutics- Opportunities, Challenges  and Advances in Drug Delivery Journal of Applied Pharmaceutical Science. 2011; 01 (09); 01-10

2. Mu W, Chu Q, Liu Y, Zhang N. A Review on Nano-Based Drug Delivery System for Cancer Chemoimmunotherapy. Nanomicro Lett. 2020;12(1):142.

3. Alvandi N, Rajabnejad M, Taghvaei Z, Esfandiari N. New generation of viral nanoparticles for targeted drug delivery in cancer therapy. J Drug Target. 2022;30(2):151-165.

4. Dong P, Rakesh KP. Innovative nano-carriers in anticancer drug delivery-a comprehensive review. Bioorganic Chemistry.2019;85: 325–336.

5.Puri R,Arora V. Magnetosomes: A Tool for Targeted Drug Delivery in the Management of Cancer. Journal of Nanomaterials.2022;1-12.

6. Lorscheider M, Gaudin A, Nakhlé J, Veiman KL, Richard J, Chassaing C. Challenges and opportunities in the delivery of cancer therapeutics: update on recent progress. Ther Deliv. 2021;12(1):55-76.

7. Mitra AK, Agrahari V, Mandal A, et al. Novel delivery approaches for cancer therapeutics. J Control Release. 2015;219:248-268.

8. Nayek S, venkatachalam A, Choudhury S. Recent nanocochleate drug delivery system for cancer treatment: a review. International Journal of Current Pharmaceutical Research 201911, 28-32.

9. https://www.insightaceanalytic.com/report/global-novel-drug-delivery-systems-in-cancer-therapy-market-/

Related Images:



Recent Images



Assessing Philippine Health Care Coverage Gaps: An Assessment of Accessibility of Public Health Programs in Selected Barangay in Imus, Cavite, Philippines
Isoabsorptive UV Spectrophotometry Method development and validation for simultaneous estimation of Eslicarbazepine Acetate and Carbamazepine
To develop and validate the stability indicating method for repaglinide and voglibose using HPLC method
To develop and validate the stability indicating method for Empagliflozin and Linagliptin using HPLC method
A Prospective Observational Study on the Clinical Evaluation of Vertigoin Young Adult Population of Amaravati Capital Region
Quality by Design-Based Analytical Method Development and Validation of Suzetrigine by RP - HPLC
Formulation, Optimization and Evaluation of Rimegepant Pulsatile Tablets for Chronotherapeutic Management of Migraine
Development and Evaluation of Ticagrelor Solid Dispersion Tablets Using PVP K30, PEG 6000 and HPMC E5 for Dissolution Enhancement
To study the effect of various superdisintegrants and binders in the Formulation and Evaluation of Labetalol Rapid Disintegrating Tablet
To Develop and Validate the Stability Indicating Method for Ezetimibe and Rosuvastatin Using HPLC Method

Tags